MedTrace Logo

Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)

NCT05296941 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-09-08

No results posted yet for this study

Summary

Cancer is a complex disease; its different causes and types have a strong impact on patient treatment and prognosis. To improve understanding of the disease, its causes and progression, the investigators will develop a simple, cost-effective system for continuous control of mucosal lesions with non-invasive brush biopsy that can be managed in primary dental care, as an alternative to tissue biopsy in order to reduce the number of oral cavity cancers.

Conditions

  • Mouth Neoplasms

Interventions

PROCEDURE

Brush sampling

Brush sampling instead of surgical biopsy for control of reaccurance

Sponsors & Collaborators

  • Uppsala University

    collaborator OTHER

  • Dalarna County Council, Sweden

    lead OTHER

Principal Investigators

  • Public dental care · Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05296941 on ClinicalTrials.gov